synthetic biology

Cathie Wood-led Ark Invest on Friday snapped up more shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the dip. The popular money manager’s investment firm snapped up 1.53 million shares — estimated to be worth $15.86 million — in the synthetic biology stock that was hit hard...

Cathie Wood-led Ark Invest on Wednesday snapped up shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the day the synthetic biology company stock was hit hard by two back-to-back short-seller reports that called the company a “colossal scam” and “a scheme.” The popular...

Cathie Wood-led Ark Invest said on Friday it continues to believe Zymergen Inc (NASDAQ: ZY)’s platform holds deep intrinsic value despite the recent setback and a lowered short-term outlook.  What Happened: Zymergen shares rallied 75% a day after Wood’s firm snapped up shares in...

A bullish Ark Invest on Wednesday more than doubled its stake in Zymergen Inc (NASDAQ: ZY) after it plummeted due to the company’s “immaterial” revenue warning. The Cathie Wood-led New York-based investment management firm snapped up 2.46 million shares, estimated...

Zymergen Inc (NASDAQ: ZY) shares continued to plummet in the pre-market trading on Tuesday. What’s Moving? The synthetic biology company which traded as high as $48.50 after it went public in April, has dived to $11 pre-market hours on Tuesday, far below its initial public offering price...